Back to Search
ALEXANDRU OLARU, M.D.
M.D.
Neurology Physician
NPI: 1447592720IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
D86828(MD)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 2000
Research & Publications (20)
Beyond the 12/23 rule of VDJ recombination independent of the Rag proteins.
PMID 15879119·J Immunol·2005
4-observational
Recombination signal sequence variations and the mechanism of patterned T-cell receptor-beta locus rearrangement.
PMID 15104124·Mol Immunol·2004
4-observational
DNA-Rag protein interactions in the control of selective D gene utilization in the TCR beta locus.
PMID 14500657·J Immunol·2003
8-other
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.
PMID 19435894·Cancer Res·2009
4-observational
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.
PMID 19296468·Hepatology·2009
4-observational
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
PMID 19670330·Int J Cancer·2009
8-other
Sensing based on assessment of non-monotonous effect determined by target analyte: case study on pore-forming compounds.
PMID 19497729·Biosens Bioelectron·2009
8-other
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
PMID 19422085·Gastroenterology·2009
7-preclinical
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.
PMID 18382671·PLoS One·2008
8-other
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
PMID 18729198·Int J Cancer·2008
8-other
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
PMID 18451147·Cancer Res·2008
4-observational
Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapy.
PMID 18575578·PLoS One·2008
8-other
Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis.
PMID 17999418·Cancer·2008
8-other
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
PMID 18199717·Cancer Epidemiol Biomarkers Prev·2008
4-observational
Rarity of Somatic Mutation and Frequency of Normal Sequence Variation Detected in Sporadic Colon Adenocarcinoma Using High-Throughput cDNA Sequencing.
PMID 18389087·Bioinform Biol Insights·2007
8-other
ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks.
PMID 17405860·Proc Natl Acad Sci U S A·2007
4-observational
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
PMID 17452981·Oncogene·2007
8-other
Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cells.
PMID 17912343·PLoS One·2007
8-other
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
PMID 17975140·Clin Cancer Res·2007
8-other
Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.
PMID 18425214·Bioinform Biol Insights·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7801 YORK RD STE 342
TOWSON, MD 21204 - Phone
- (410) 321-6055
Quick Facts
- NPI
- 1447592720
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile